DC Chemicals

All products / DC9481

Didanosine
CAT. NO. DC9481

Didanosine

Pack sizes and prices

Pack sizePrice
100 mg$300 USDRequest a quote →
250 mg$600 USDRequest a quote →
1 g$1,200 USDRequest a quote →

In stock. Contact our team for lead time, shipping and final quotation.

Product overview

Didanosine(Videx) is a reverse transcriptase inhibitor with an IC50 of 0.49 μM. Didanosine is a dideoxynucleoside compound in which the 3'-hydroxy group on the sugar moiety has been replaced by a hydrogen. This modification prevents the formation of phosphodiester linkages which are needed for the completion of nucleic acid chains. Didanosine is a potent inhibitor of HIV replication, acting as a chain-terminator of viral DNA by binding to reverse transcriptase. Didanosine demonstrated linear pharmacokinetic behavior over the dose ranges of 0.4 to 16.5 mg/kg intravenously and 0.8 to 10.2 mg/kg orally. Bioavailability of didanosine when administered as a solution with an antacid was approximately 43% for doses from 0.8 to 10.2 mg/kg in patients with AIDS and advanced AIDS-related complex. Bioavailability of didanosine from the citrate-phosphate-buffered solution, the formulation currently used in phase II and expanded access studies, was comparable to the formulation used in the phase I trials. ddI might be responsible for fulminant hepatitis in all three AIDS patients. This toxic effect may be added to the list of potential adverse events occurring during ddI therapy.

For research use only. Results depend on experimental conditions and do not constitute a performance guarantee.

Identity and specifications

Catalog numberDC9481
Product nameDidanosine
CAS69655-05-6
Molecular formulaC10H12N4O3
Molecular weight236.2273
Purity>98%
SMILESOC[C@@H]1CC[C@H](N2C=NC3=C2N=CN=C3O)O1

Source-listed specifications; the batch COA applies.

Source and product documents

The supplier source is linked below. Contact us for COA, SDS and batch-specific documents.

DC Chemicals — Didanosine (DC9481)

Related research products